Ticarcillin monosodium, a semisynthetic carboxypenicillin antibacterial agent, exhibits broad-spectrum activity against gram-positive cocci such as streptococci and staphylococci. It is also effective against most gram-negative organisms, notably Pseudomonas aeruginosa. The compound is utilized in the treatment of various infections, including those of the lower respiratory tract, skin and skin structures, urinary tract, and intraabdominal infections, according to research [1] [2] [3].